Digest Network Come funziona
Digest / Comunicato

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.

FonteFine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente 1INFO
Compatibilità
Salva(0)
Condividi
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.
Materiali Allegati (1)

20094_151100_2025_oneinfo.pdf

Scarica Press Kit ->
Recapiti

Comunicati correlati

14/11/2024
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
THE BOARD OF DIRECTORS OF FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. TODAY APPROVED THE GROUP'S INTERIM FINANCIAL REPORT AS OF 30 SEPTEMBER 2024. ADJUSTED EBITDA OF € 23.4 MILLION (+27.8%)
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0
13/09/2024
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
THE BOARD OF DIRECTORS OF FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A APPROVED THE 30 JUNE 2024 HALF-YEAR FINANCIAL REPORT: RECORD FIRST-HALF EBITDA OF € 16 MILLION AND A STRONG PROFITABILITY INCREASE
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0
28/02/2025
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
Pietro Oriani confirmed as Chief Executive Officer - EY appointed to certify sustainability report compliance
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0